Tagged Articles

AbbVie 91 articles

AndroGel needed heart risk warning, witness says

Peggy Pence, the president and CEO of pharmaceutical consulting firm Symbion Research International Inc., told an Illinois federal jury that there was enough evidence that testosterone replacement therapies may cause heart attacks that warnings should be placed on the hormone treatments’ labels and further testing should be conducted, Law360 reports. Pence told the jury in the first bellwether among thousands in a multidistrict litigation (MDL) to go to trial alleging cardiovascular risks with testosterone treatments that Abbvie had received so many reports of heart problems in patients who had used its AndroGel testosterone gel that further testing was warranted. Pence ... Read More

Did AbbVie fabricate ‘Low T’ to sell more product?

AbbVie Inc. fabricated a condition called Low T to lure men without hypogonadism to use its testosterone replacement therapy AndroGel but didn’t tell them that using the hormone treatment could put them at risk of life threatening heart attacks, attorneys for an AndroGel user who nearly died told an Illinois federal jury. The case of Jesse Mitchell versus AbbVie is the second bellwether to go to trial among thousands lodged against AbbVie and other testosterone treatment manufacturers. The first ended in a mistrial when the plaintiff’s lead attorney fell ill. That trial was rescheduled for September. Those suing the drug ... Read More

Axiron side effects trial dates set

Two cases among more than 6,000 lawsuits waged against Eli Lilly and Co. over testosterone side effects have been selected by the U.S. District Court for the Northern District of Illinois to serve as bellwether trials in the Testosterone Replacement Therapy Product Liability multidistrict litigation (MDL). U.S. District Judge Matthew K. Kennelly selected the case of Tracy Garner and the case of John Debroka Jr. to serve as bellwethers. Garner claims to have had a heart attack after initiating testosterone therapy with Lilly’s Axiron. Debroka alleges he developed deep vein thrombosis, a blood clot deep in the veins, after taking ... Read More

Testosterone clinics open despite health risks

At least three hormone replacement clinics have opened in the Cypress-Fairbanks area of Texas in recent months promoting the benefits of testosterone replacement therapy despite recent studies that have raised safety concerns about the treatments. “Men’s testosterone levels decrease as they age, and that’s not new,” Jason Starr, owner of Men’s T Clinic, told Community Impact Newsletter. “What is newer is this notion that men no longer have to accept it.” That’s the message manufacturers of testosterone replacement therapy have touted with aggressive advertising campaigns aimed at men. The ads claim that so-called “Low T” can cause symptoms such as a ... Read More

First two Axiron side effects trials scheduled

AbbVie isn’t the only testosterone treatment manufacturer facing heat in the multidistrict litigation (MDL) alleging the hormone treatment is linked to heart attacks, strokes, blood clots and deaths. This week, the Illinois federal judge overseeing the MDL selected the first two cases that will go to trial against Eli Lilly and Co., according to Law360. AbbVie faces the first bellwether trials in the MDL, with the latest ending in mistrial earlier this month after the lead plaintiff’s attorney fell ill. That case will be retried in September. AbbVie , maker of the top selling AndroGel, will strand trial in the ... Read More

Man blames heart attack on Low T therapy

Tracy Garner was intrigued by advertisements for testosterone replacement therapy to boost sex drive and improve muscle mass in men with “Low T.” He asked is doctor about the hormone therapy, and in March 2013, Garner was prescribed Eli Lilly and Co.’s Axiron. A few days later, he had a heart attack. Garner is one of about 6,000 men suing manufacturers of testosterone replacement therapy, alleging the drug companies engaged in aggressive marketing of a prescription drug for off-label use – the treatment of so-called Low T, according to Law360. Testosterone treatments are intended for men with hypogonadism, a condition ... Read More

Doctor says testosterone treatment has heart risks

Days before the a lead attorney in the first bellwether trial alleging cardiovascular risks with the testosterone replacement therapy AndroGel fell ill, resulting in a mistrial, a cardiologist who teaches at Northwestern University testified that he believes testosterone treatments increase the risk of heart attacks in older men, Law360 reported. Dr. Hossein Ardehali appeared as an expert witness in the case of Jeffrey Konrad, a Tennessee man who says he was lured by aggressive advertising by AbbVie and other testosterone treatment manufacturers to try the medication to treat symptoms of so-called Low T, a condition allegedly fabricated by manufacturers of ... Read More

Boy awarded $15M in Depakote birth defects trial

A 10-year-old boy was awarded $15 million by an Illinois federal jury over claims that Abbott Laboratories’ did not adequately warn doctors that its anti-seizure and bipolar drug Depakote could cause severe birth defects, according to Law360. The jury deliberated nearly two full days, ultimately agreeing with attorneys for Stevie Gonzalez and his family that doctors who prescribed the drug to his mother, Christina Raquel, were not aware that there was at least a 10 percent chance that she could give birth to a baby with spina bifida or another major malformation. Raquel became pregnant with Gonzalez months after starting ... Read More

First testosterone lawsuit ends in mistrial

The much-anticipated first bellwether trial against AbbVie Inc. over alleged adverse cardiovascular side effects with its testosterone replacement therapy AndroGel ended in a mistrial this week after the lead plaintiff’s attorney was hospitalized due to an illness, according to Law360. The trial involved the case of Jeffrey Konrad, a Tennessee man who claims in 2010 he was lured to try testosterone therapy after watching advertisements promoting testosterone treatment for the so-called condition, Low T. The ads assured him that AndroGel could improve Low-T symptoms such as low sex drive, weight gain and depressed mood. Konrad asked his doctor to prescribe ... Read More

Former FDA chief testifies at testosterone trial

Former Food and Drug Administration (FDA) Commissioner David Kessler told jurors in the first bellwether trial over alleged testosterone side effects that in his opinion manufacturers of the male hormone overstepped federal regulatory boundaries when they aggressively marketed the treatment directly to consumers without proper testing, according to Law360. Kessler was called as the first witness in the case of Jeffrey Konrad, who claims that he was lured by AbbVie’s ads for the testosterone gel AndroGel for a condition the drug company made up called “Low T.” The ads claimed that Low T could cause low libido, weight gain, muscle ... Read More